We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Asks Drugmakers to Avoid Using Two Phthalate Products
FDA Asks Drugmakers to Avoid Using Two Phthalate Products
January 2, 2013
Sponsors of treatments containing two types of phthalates may wish to contact the appropriate Center for Drug Evaluation and Research (CDER) review division to determine what studies supporting alternative excipients may be required, according to an FDA final guidance.